• Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet

ISDB – International Society of Drug Bulletins

International Society of Drug Bulletins

  • Home
  • About ISDB
    • What is ISDB?
    • Committee
    • Constitution
  • How to join
    • COI-forms
    • Criteria for membership
    • Application forms
  • Members
    • Bulletin index
    • Full members
    • Associated members
  • Publications
    • Newsletters
    • ISDB Publications
    • Press releases
    • Documents of interest
  • Campaigns
    • Working groups
    • Petitions
    • Future meetings
    • Past meetings
  • Intranet
  • Menu

‘Investor-to-state dispute settlement’ in EU-US trade deal threatens access to affordable medicines

July 11, 2014 Press releases, Publications

‘Investor-to-state dispute settlement’ in EU-US trade deal threatens access to affordable medicines

Attachment: 20140711_isdsinttip.pdf

Recent Publications

  • ISDB Newsletter July 2024
  • ISDB Newsletter March 2024
  • ISDB Newsletter October 2023
  • ISDB response to the public consultation on the Clinical Trials Regulation and its information system
  • ISDB Newsletter April 2023

Newsletter

Recent Campaigns

  • Letter to the Australian Health Minister in support of Australian Prescriber
  • Letter to Charles Michel on transparency in EU institutions
  • A letter to the Prime Minister of India
  • ISDB General Assembly Paris 2019
  • News from working groups: Clinical Study Reports?

Contact

President
Rita Kessler
president@isdbweb.org

Sign up to receive our newsletter.

Press releases

  • Statement: COVID-19 [EN]
  • ISDB General Assembly Paris 2019
  • Cochrane’s sinking ship and conflicts of interest
  • No to EMA’s provision of confidential scientific advice to drug companies (November 2017)
  • Supplementary protection certificates (SPCs) delay access to affordable medicines (September 2017)

Newsletters

  • ISDB Newsletter July 2024
  • ISDB Newsletter March 2024
  • ISDB Newsletter October 2023
  • ISDB Newsletter April 2023
  • ISDB Newsletter September 2022

© 2024 ISDB – International Society of Drug Bulletins.